Groupement De Cooperation Sanitaire Risssa Recherche & Innovation Sante Sarcelles — Clinical Trial Site

9 Registered trials

5 Currently recruiting

Organisation

Groupement De Cooperation Sanitaire Risssa Recherche & Innovation Sante Sarcelles

Location

Sarcelles, France

Identifier

ORG-100045743

Address

6 Avenue Charles Peguy, 95200, France

Departments

Medical oncology
Oncologie
Oncologie médicale
Oncologie Radiothérapie
Oncology-Radiotherapy
Radiotherapy

Clinical trials at this site (9)

Search interface

Phase 3 study comparing ivonescimab alone or ivonescimab with ligufalimab versus pembrolizumab for the first-line treatment of recurrent and… Recruiting

2025-522996-27-00 recurrent and/or metastatic squamous cell carcinoma of 5 2026-05-05
NoLEEta - Phase III non-inferiority trial of chemotherapy de-escalation in hormone receptorpositive, Her2-negative, intermediate-risk early … Recruiting

2025-520979-13-00 Patients with HR+ HER2- early breast cancer at intermed 5 2025-12-18
Treatment with darolutamide +/- radiation therapy for patients with a castration resistant cancer and metastases detected by functional imag… Recruiting

2023-509787-15-00 Patients with localised prostate cancer and high-risk f 5 2025-02-17
PRODIGE 70 - CIRCULATE - CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II Recruiting

2024-515297-27-00 colon carcinoma 5 2024-08-14
Non inferiority study of preoperative chemotherapy without pelvic irradiation for rectal cancer Recruiting

2024-510580-28-00 Middle or low locally advanced resectable rectal carcin 5 2019-06-05
Safety and efficacy analysis of an antibody associated with a chemotherapy for patients with a triple negative metastatic breast cancer. Ended

2022-502369-10-00 Triple negative metastatic breast cancer 5 2023-10-02
Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23
Comparing two treatment regimen for sinuses tumors and salivary glands: radiotherapy versus chemoradiotherapy Ended

2024-513972-16-00 - Resected tumors of sinuses or salivary glands - Non-o 5 2017-01-30
Chemotherapy or chemotherapy + hormonotherapy in women over 70 with HER2 receptor-negative but estrogen receptor-positive breast cancer acco… Ended

2024-516996-34-00 oestrogen-receptor (ER)-positive HER2-negative breast c 5 2012-04-12